Violet Therapeutics
PrivateLast Round
Seed
May 13, 2026
Total Funding Raised
$15.35M
Momentum Score
50 /100
Company Overview
Violet Therapeutics is a biotechnology company that offers a drug discovery platform for identifying and analyzing cellular connectomes at scale, utilizing barcoded viral tracing to enhance understanding of cell-cell interactions and support advancements in neuroinflammation treatments.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Violet Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Violet Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 13, 2026 | ||||
| Seed | May 31, 2023 |
Violet Therapeutics Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
$4.75M round led by LifeSpan Vision Ventures.
Violet Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Violet Therapeutics's valuation, stock price, and market status.
